The national drug regulator has given the green light to the Novavax vaccine, along with two oral treatments for patients currently suffering from COVID-19. The Therapeutic Goods Administration (TGA) on Thursday approved the Novavax vaccine, also called Nuvaxovid, for adults aged 18 years and over, making it the first protein-based COVID-19 vaccine in the country’s…